Kewaunee Scientific (NASDAQ: KEQU) releases FY26 Q1 results update

Rhea-AI Filing Summary

Kewaunee Scientific Corporation filed a current report to let investors know it has released financial results for the first quarter of its fiscal year 2026. The company states that these results were announced in a press release dated September 10, 2025, which is provided as Exhibit 99.1.

The report explains that this press release is being furnished, rather than filed, which limits how it is treated under securities laws. Kewaunee’s common stock continues to trade on the Nasdaq Global Market under the symbol KEQU.

KEWAUNEE SCIENTIFIC CORP /DE/FALSE000005552900000555292025-09-102025-09-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 10, 2025

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

Delaware

0-5286

38-0715562

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(IRS Employer Identification No.)

2700 West Front Street

Statesville, NC 28677

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

N/A

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $2.50 par value

KEQU

The Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On September 10, 2025, Kewaunee Scientific Corporation issued a press release announcing its financial results for the first quarter of fiscal year 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press Release of Kewaunee Scientific Corporation dated September 10, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

						KEWAUNEE SCIENTIFIC CORPORATION                              (Registrant)
Date: September 10, 2025						By			/s/ Donald T. Gardner III
									Donald T. Gardner III
									Vice President, Finance
									Chief Financial Officer

FAQ

What did Kewaunee Scientific (KEQU) disclose in this Form 8-K?

Kewaunee Scientific disclosed that it issued a press release announcing its financial results for the first quarter of fiscal year 2026, furnished as Exhibit 99.1.

Which financial period does Kewaunee Scientific’s latest update cover?

The update covers Kewaunee Scientific’s financial results for the first quarter of its fiscal year 2026.

Where can investors find the detailed Q1 FY26 results for Kewaunee Scientific (KEQU)?

The detailed first quarter fiscal 2026 financial results are contained in the company’s press release furnished as Exhibit 99.1 to this report.

Is the Kewaunee Scientific Q1 FY26 press release considered filed with the SEC?

No. The report states that the information in the current report, including Exhibit 99.1, is being furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act.

What exhibits are included with Kewaunee Scientific’s Q1 FY26 8-K?

The report includes Exhibit 99.1, the press release announcing Q1 FY26 financial results, and Exhibit 104, the cover page interactive data file embedded in the Inline XBRL document.

On which exchange is Kewaunee Scientific’s common stock listed and under what symbol?

Kewaunee Scientific’s common stock is listed on The Nasdaq Global Market under the trading symbol KEQU.